
Despite emotional testimony from women who say their breast implants made them sick with cancer or autoimmune symptoms, the Food and Drug Administration (FDA) has no plans to ban the textured implants that are being blamed.

Despite emotional testimony from women who say their breast implants made them sick with cancer or autoimmune symptoms, the Food and Drug Administration (FDA) has no plans to ban the textured implants that are being blamed.

The FDA announced on March 27, 2019 that it is working to update mammography regulations, expanding the amount of information that mammography facilities must give patients and healthcare professionals.

Three sisters trace their family’s experiences with breast and ovarian cancer across generations.

By the time 14 months of treatment were through, I was watching a woman I no longer recognized and could not bear to look at in the mirror. I realized that to truly be a survivor, I had to readjust my expectations of myself.

Enormous progress has been made in breast cancer, yet many challenges remain, according to Ann H. Partridge, M.D., MPH.

In metastatic breast cancer, the brain MRI is often a special request for what you don't want but truly need.

Debu Tripathy, M.D., the editor in chief of CURE®, recently sat down at the Miami Breast Cancer Conference to discuss the importance of oncology nurses in breast cancer care and offered insight as to how they can keep up-to-date with the constant advancements in the field.

Adam Brufsky, M.D., Ph.D. discussed treatments for BRCA-positive breast cancer at the 2019 Miami Breast Cancer Conference.

Breast cancer is no laughing matter, but being able to find something to laugh about in the midst of the trial can be cathartic.

Of all the things that cancer left me with, scarred veins in my only good arm has been the worst. I have learned to treasure those techs who can find a good vein and hit it the first time.

In this week’s episode, we spoke with Linda Tantawi about Susan G. Komen Greater New York City, and how the organization is connecting communities to educate women about breast cancer.

Rose Gerber, of the Community Oncology Alliance, shared her story of participating in a clinical trial and hopes for others to help educate patients with breast cancer to increase participation moving forward.

At CURE’s patient-focused meeting at the 36th Annual Miami Breast Cancer Conference, Shannon Pulaski and Ellen Matloff discussed the importance of genetic counseling and learning more about one’s family health history.

The Food and Drug Administration (FDA) has granted an approval to Trazimera (PF-05280014; trastuzumab-qyyp), a Herceptin (trastuzumab) biosimilar, to treat patients with HER2-overexpressing breast cancer as well as HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma.

Many people believe that genetic testing for cancer can only be beneficial for individuals with a strong family history of the disease, but that is not necessarily the case.

Can at-home DNA testing kits accurately help us discover important health information? What do we do with the information once we receive it? In this post, learn more about the pros and cons.

The Food and Drug Administration approved the VENTANA PD-L1 (SP142) Assay as the first companion diagnostic to aid in identifying patients with triple-negative breast cancer who are eligible for treatment with Tecentriq (atezolizumab) plus chemotherapy.

Breast cancer treatment is a life-saver but also can have side effects, including some related to shoulder pain. It is good to start doing the exercises as soon as the doctor recommends it. After that, a regular tune-up with a physical therapist can help.

The Food and Drug Administration has granted an accelerated approval to the frontline combination of Tecentriq (atezolizumab) plus Abraxane (nab-paclitaxel) for patients with unresectable locally advanced or metastatic PD-L1–positive triple-negative breast cancer (TNBC).

We've got a sneak peek at what’s inside our Winter 2019 issue.

This survivor details her journey with breast implants following a modified radical mastectomy.

CURE® sponsors a fun and free introduction to this playful practice for health and healing.

The one-day agenda hosts faculty and panels discussing breast cancer treatments and their side effects, genetics, survivorship, and more.

The former NFL running back opens up about his mother’s battle with breast cancer.

What happens when the trick goes wrong?